Activity of ceftaroline against community associated and healthcare associated methicillin resistant Staphylococcus aureus

Pathology. 2014 Jan;46(1):71-3. doi: 10.1097/PAT.0000000000000032.

Authors

Geoffrey W Coombs¹, Julie C Pearson, James O Robinson, Keryn J Christiansen

Affiliation

¹ 1Australian Collaborating Centre for Enterococcus and Staphylococcus Species (ACCESS) Typing and Research, School of Biomedical Sciences, Curtin University 2Department of Microbiology and Infectious Diseases, PathWest Laboratory Medicine - WA, Royal Perth Hospital 3Royal Perth Hospital, Perth, WA, Australia.

PMID: 24300719
DOI: 10.1097/PAT.0000000000000032

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology*
Ceftaroline
Cephalosporins / pharmacology*
Community-Acquired Infections
Cross Infection
Humans
Methicillin-Resistant Staphylococcus aureus / classification
Methicillin-Resistant Staphylococcus aureus / drug effects*
Methicillin-Resistant Staphylococcus aureus / genetics
Microbial Sensitivity Tests
Staphylococcal Infections / drug therapy*
Staphylococcal Infections / microbiology

Substances

Anti-Bacterial Agents
Cephalosporins